Several IOP-lowering glaucoma medications were also evaluated for their effects on aqueous hydrodynamics in the mouse. We confirmed that the prostaglandin FP agonist latanoprost, the β-blocker betaxolol, and the α
2-adrenergic agonist brimonidine lowered IOP, similarly to previous studies.
27,45 –51 We also found that latanoprost increased C without affecting Fin or Fu in the present study (
Fig. 4). These results are in agreement with the findings of Avila et al.,
31 who showed that latanoprost increases the rate of fluorescein decay in the aqueous of three strains of mice (Black Swiss, DBA/2J, C57BL/6), suggesting improvement of aqueous outflow facility. Crowston et al.
27 also reported that latanoprost, when applied topically to the mouse eye, lowered IOP by ∼11% and increased C by ∼40% without affecting Fu. Fin measured by the rhodamine-dextran dilution method was unaffected by latanoprost treatment.
27,28 The lack of effect of latanoprost on mouse Fu is different from that on primate Fu. Prostaglandin FP agonists significantly increase monkey and human Fu, presumably via their actions on the ciliary muscle.
32,33,52,53 However, the ciliary muscle is not as well developed in the mouse eye and is unlikely to be involved in the regulation of aqueous humor outflow compared with the primates.
36 Interestingly, we also observed that latanoprost induced a significant reduction in mouse Pe (
Fig. 4). This finding is of interest and warrants further investigation. Brubaker
54 cited a human study in which the prostanoid bimatoprost reduced tonographic resistance to aqueous outflow by 26%. However, this reduction in outflow resistance was inadequate to account for the observed reduction in IOP, and thus it was concluded that bimatoprost may also reduce Pe (although in this study no attempt to measure Pe was made). However, no reports exist as yet in the literature indicating any effects of other prostanoids, such as latanoprost or travoprost, on this parameter.
55 –57 The biological significance of these findings has yet to be elucidated.